Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta-analysis

International Journal of Cancer

Volumn 128, Issue 1, 2011, Pages 176-184

  Cho, Lisa Y ^a   Yang, Jae Jeong ^a   Ko, Kwang Pil ^a,b   Park, Boyoung ^a   Shin, Aesun ^c   Lim, Min Kyung ^c   Oh, Jin Kyoung ^c   Park, Sohee ^c   Kim, Yoon Jun ^a   Shin, Hai Rim ^c,d   Yoo, Keun Young ^a   Park, Sue K ^a  

^a Seoul National University   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

^c National Cancer Center   (South Korea)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Meta analysis; Sub additive effect

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ARTICLE; CANCER RISK; CHINA; CLINICAL EVALUATION; CLINICAL TRIAL; DISEASE ASSOCIATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INFORMATION RETRIEVAL; LIVER CELL CARCINOMA; META ANALYSIS; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VIRUS INFECTIVITY;

CARCINOMA, HEPATOCELLULAR; CHINA; HEPATITIS B; HEPATITIS C; HUMANS; KOREA; LIVER NEOPLASMS; SPAIN; TAIWAN; UNITED STATES;

EID: 78349254934     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25321     Document Type: Article

References (80)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74 108.
2. Lu SN, Su WW, Yang SS, Chang TT, Cheng KS, Wu JC, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 2006; 119: 1946 52.
3. Sato S, Fujiyama S, Tanaka M, Yamasaki K, Kuramoto I, Kawano S, Sato T, Mizuno K, Nonaka S,. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994; 21: 159 66.
4. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, Tran van Nhieu J, Seigneurin JM, Buffet C, Dhumeaux D,. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998; 28: 27 33.
5. Kuper HE, Tzonou A, Kaklamani E, Hadziyannis S, Tasopoulos N, Lagiou P, Trichopoulos D, Stuver S,. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays. Cancer Causes Control 2000; 11: 171 5.
6. Hadziyannis S, Tabor E, Kaklamani E, Tzonou A, Stuver S, Tassopoulos N, Mueller N, Trichopoulos D,. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. Int J Cancer 1995; 60: 627 31.
7. Donato F, Tagger A, Chiesa R, Ribero ML, Tomasoni V, Fasola M, Gelatti U, Portera G, Boffetta P, Nardi G,. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology 1997; 26: 579 84.
8. Ayoola EA, Gadour MO,. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. J Gastroenterol Hepatol 2004; 19: 665 9.
9. Tangkijvanich P, Theamboonlers A, Sriponthong M, Kullavanijaya P, Poovorawan Y,. SEN virus infection and the risk of hepatocellular carcinoma: a case-control study. Am J Gastroenterol 2003; 98: 2500 4.
10. El-Serag HB, Richardson PA, Everhart JE,. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol 2001; 96: 2462 7.
11. Stroffolini T, Chiaramonte M, Tiribelli C, Villa E, Simonetti RG, Rapicetta M, Stazi MA, Bertin T, Croce SL, Trande P, et al. Hepatitis C virus infection HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol 1992; 16: 360 3.
12. Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, Gelatti U, Albertini A, Fasola M, Boffetta P, Nardi G,. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study. Int J Cancer 1999; 81: 695 9.
13. Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H,. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol 1998; 27: 574 8.
14. Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY, Tsai JH,. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br J Cancer 1996; 73: 1498 502.
15. Tanaka H, Tsukuma H, Yamano H, Oshima A, Shibata H,. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus. Int J Cancer 2004; 112: 1075 80.
16. Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ, Hainaut P, Hall AJ, Whittle H, Montesano R,. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 2004; 39: 211 19.
17. Wang CS, W.J. Y, Chang TT, Wang ST, Chou P,. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev 2009; 18: 2054 60.
18. Chuang WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, Hsieh MY, Wang LY, You SL, Chen CJ,. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer 1992; 69: 2052 4.
19. Donato F, Boffetta P, Puoti M,. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998; 75: 347 54.
20. Shi J, Zhu L, Liu S, Xie WF,. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005; 92: 607 12.
21. Chu CM, Yeh CT, Liaw YF,. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 1998; 36: 2084 6.
22. Sheen IS, Liaw YF, Chu CM, Pao CC,. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 1992; 165: 831 4.
23. Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M, Naramoto J,. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000; 151: 131 9.
24. Sun CA, Wu DM, Lin CC, Lu SN, You SL, Wang LY, Wu MH, Chen CJ,. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol 2003; 157: 674 82.
25. Jee SH, Ohrr H, Sull JW, Samet JM,. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004; 96: 1851 6.
26. Lai MS, Hsieh MS, Chiu YH, Chen TH,. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006; 43: 1295 302.
27. Gwack J, Hwang SS, Ko KP, Jun JK, Park SK, Chang SH, Shin HR, Yoo KY,. [ Fasting serum glucose and subsequent liver cancer risk in a Korean prospective cohort ]. J Prev Med Public Health 2007; 40: 23 8.
28. Wang N, Zheng Y, Yu X, Lin W, Chen Y, Jiang Q,. Sex-modified effect of hepatitis B virus infection on mortality from primary liver cancer. Am J Epidemiol 2009; 169: 990 5.
29. Kao JH, Chen DS,. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2: 395 403.
30. Immunization Action Coalition: vaccination information for healthcare professionals.
31. Hardy RJ, Thompson SG,. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998; 17: 841 56.
32. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088 101.
33. Egger M, Smith GD, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629 34.
34. Lu SN, Lee CM, Changchien CS, Chen CJ,. Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country (Taiwan). Trans R Soc Trop Med Hyg 1999; 93: 600 2.
35. Ezzat S, Abdel-Hamid M, Eissa SA, Mokhtar N, Labib NA, El-Ghorory L, Mikhail NN, Abdel-Hamid A, Hifnawy T, Strickland GT, Loffredo CA,. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health 2005; 208: 329 39.
36. Di Bisceglie AM, Order SE, Klein JL, Waggoner JG, Sjogren MH, Kuo G, Houghton M, Choo QL, Hoofnagle JH,. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991; 86: 335 8.
37. Cordier S, Le TB, Verger P, Bard D, Le CD, Larouze B, Dazza MC, Hoang TQ, Abenhaim L,. Viral infections and chemical exposures as risk factors for hepatocellular carcinoma in Vietnam. Int J Cancer 1993; 55: 196 201.
38. Cao K, Mizokami M, Orito E, Ding X, Ueda R, Chen G, Yu SZ, Tokudome S,. GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma in the inshore area of the Yangtze River, China. J Gastroenterol Hepatol 1998; 13: 1241 8.
39. Franceschi S, Montella M, Polesel J, La Vecchia C, Crispo A, Dal Maso L, Casarin P, Izzo F, Tommasi LG, Chemin I, Trepo C, Crovatto M, et al. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev 2006; 15: 683 9.
40. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK,. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007; 22: 1104 11.
41. Han BH, Lee SW, Koo JY, Park BC,. Prevalence of hepatitis B and C viral markers in patients with hepatocellular carcinoma in Korea. J Korean Cancer Assoc 1991; 23: 723 7.
42. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, Ahn YO, Shigemastu T,. Hepatitis B and C virus Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996; 25: 933 40.
43. Tanaka K, Ikematsu H, Hirohata T, Kashiwagi S,. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection. J Natl Cancer Inst 1996; 88: 742 6.
44. Tsai JF, Chuang LY, Jeng JE, Ho MS, Hsieh MY, Lin ZY, Wang LY,. Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study. Br J Cancer 2001; 84: 709 13.
45. Tseng CS, Tang KS, Lo HW, Ker CG, Teng HC, Huang CS,. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol 2005; 100: 1758 63.
46. Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG,. Heat shock protein A1B 1267 polymorphism is highly associated with risk and prognosis of hepatocellular carcinoma: a case-control study. Medicine (Baltimore) 2008; 87: 87 98.
47. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxi A, Ciccaglione A, Giuseppetti R, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116: 97 102.
48. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ,. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991; 51: 5621 5.
49. Huh K, Lee JK, Choi SY, Hong SI, Lee DS,. A study on the prevalence of HBsAg and anti-HCV in patients with hepatocellular carcinoma: comparative study with healthy blood donors. Korean J Clin Pathol 1998; 18: 459 63.
50. Kao JH,. Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Rev Gastroenterol Hepatol 2008; 2: 553 62.
51. Monto A, Wright TL,. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 2001; 28: 441 9.
52. Schuttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S,. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 2002; 37: 855 62.
53. Kane M,. Global programme for control of hepatitis B infection. Vaccine 1995; 13 (suppl 1): S47 S49.
54. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA,. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 2002; 963: 13 20.
55. Marrero CR, Marrero JA,. Viral hepatitis and hepatocellular carcinoma. Arch Med Res 2007; 38: 612 20.
56. Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A,. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 1995; 345: 1089 92.
57. Ng KP, Saw TL, Baki A, Rozainah K, Pang KW, Ramanathan M,. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol 2005; 194: 163 8.
58. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS,. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31: 777 82.
59. El-Serag HB,. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002; 36: S74 S83.
60. Schutte K, Bornschein J, Malfertheiner P,. Hepatocellular carcinoma epidemiological trends and risk factors. Dig Dis 2009; 27: 80 92.
61. Ju YH, Oh JK, Kong HJ, Sohn WM, Kim JI, Jung KY, Kim YG, Shin HR,. [ Epidemiologic study of Clonorchis sinensis infestation in a rural area of Kyongsangnam-do South Korea ]. J Prev Med Public Health 2005; 38: 425 30.
62. Lun ZR, Gasser RB, Lai DH, Li AX, Zhu XQ, Yu XB, Fang YY,. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis 2005; 5: 31 41.
63. Chen ER,. Clonorchiasis in Taiwan. Southeast Asian J Trop Med Public Health 1991; 22 (suppl): 184 185.
64. Mohamed AE, Kew MC, Groeneveld HT,. Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African blacks. Int J Cancer 1992; 51: 537 41.
65. Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, Chang WY, Sheen MC, Lin TM,. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991; 13: 398 406.
66. El-Serag HB,. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002; 35: S72 S8.
67. Michielsen PP, Francque SM, van Dongen JL,. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol 2005; 3: 27.
68. Shiratori Y,. Epidemiology and natural course of HCV infection. Korea: The Korean Association for the Study of the Liver, 2004.
69. Brotman B, Prince AM, Huima T, Richardson L, van den Ende MC, Pfeifer U,. Interference between non-A, non-B and hepatitis B virus infection in chimpanzees. J Med Virol 1983; 11: 191 205.
70. Bradley DW, Maynard JE, McCaustland KA, Murphy BL, Cook EH, Ebert JW,. Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections. J Med Virol 1983; 11: 207 13.
71. Ohkawa K, Hayashi N, Yuki N, Masuzawa M, Kato M, Yamamoto K, Hosotsubo H, Deguchi M, Katayama K, Kasahara A, et al. Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses. J Med Virol 1995; 46: 258 64.
72. Mathurin P, Thibault V, Kadidja K, Ganne-Carrie N, Moussalli J, El Younsi M, Di Martino V, Lunel F, Charlotte F, Vidaud M, Opolon P, Poynard T,. Replication status and histological features of patients with triple (B. C, D) and dual (B, C) hepatic infections. J Viral Hepat 2000; 7: 15 22.
73. Squadrito G, Orlando ME, Pollicino T, Raffa G, Restuccia T, Cacciola I, Di Marco V, Picciotto A, Colucci G, Craxi A, Raimondo G,. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am J Gastroenterol 2002; 97: 1518 23.
74. Chen SY, Kao CF, Chen CM, Shih CM, Hsu MJ, Chao CH, Wang SH, You LR, Lee YH,. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 2003; 278: 591 607.
75. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, Law MG,. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006; 45: 197 203.
76. Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, Hsu ST,. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988; 62: 2051 5.
77. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G,. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341: 22 6.
78. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF, Jr,. International trends and patterns of primary liver cancer. Int J Cancer 2001; 94: 290 6.
79. Bosch FX, Ribes J, Diaz M, Cleries R,. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5 S16.
80. Pujol FH, Navas MC, Hainaut P, Chemin I,. Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma. Cancer Lett 2009; 286: 80 8.